TECH Bio-Techne Corporation Total Debt to Capital

The historical price chart for the separate_debt_total_eq metric stands at 0.14, illustrating the financial condition of Bio-Techne Corporation (TECH). Bio-Techne Corporation attracts leading scientists through generous research investments and the social value of its projects. The business extracts high margins from the sale of reagents, which are inexpensive to produce. Patent protection and the integration of products into customer workflows create a powerful barrier for competitors.

Investors utilize this indicator to assess debt load and financial autonomy during the initial screening of assets. The total liabilities-to-equity ratio, currently 0.14, confirms the stability of Bio-Techne Corporation (TECH), whose diversified supply network to global laboratories minimizes default risks, as clearly reflected by the financial stability ratio (debt-to-equity).